Investor presentation
In brief · summary, not quotable
No summary for this filing – the full text is below.
Full announcement
Select text to share a quote on X · sign in to keep highlights & notes in your GDR notes
As previously announced, genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company, will release its interim results for the six months ended 31 December 2023 on 28 March 2024.
The Company will provide a live presentation to accompany the results, presented by Chief Executive Officer James Cheek, Chief Financial Officer Russ Shaw and Chief Scientific Officer Gino Miele, on Friday, 5 April 2024 at 10.00am.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.